Skip to main content
. 2020 Jul 22;10:1067. doi: 10.3389/fonc.2020.01067

Figure 3.

Figure 3

PD-L1 is targeted by miR-429 to mediate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity. (A) Binding of miR-429 and PD-L1 predicted from starBase. The position of the 3′-UTR binding targets of miR-429 and PD-L1 were predicted on TargetScan. (B) mRNA expressions of PD-L1 in SGC7901, BGC823, MKN45, and HGC27 cells via quantitative PCR (qPCR). (C) Western blot analysis of PD-L1 expressions in SGC7901, BGC823, MKN45, and HGC27 cells. (D) Expressions of PD-L1 in tumor and normal tissues analyzed using the TCGA database on the GEPIA2 website. Results are the mean ± SEM of triplicate samples from three independent experiments. *P < 0.05, **P < 0.01.